Sein Néoadjuvant
EMBER-2 (J2J-MC-JZLB)
EMBER-2: A Phase 1, Open-Label, Preoperative Window Study Evaluating the Biological Effects of LY3484356 in Post-menopausal Women With Stage I-III Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Saint-Cloud
FRANCOIS-CLEMENT BIDARD